107 related articles for article (PubMed ID: 8372596)
1. Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.
Schoot DC; Hop WC; Pache TD; de Jong FH; Fauser BC
Acta Endocrinol (Copenh); 1993 Aug; 129(2):126-9. PubMed ID: 8372596
[TBL] [Abstract][Full Text] [Related]
2. The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome.
Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
Hum Reprod; 1993 May; 8(5):699-704. PubMed ID: 8314962
[TBL] [Abstract][Full Text] [Related]
3. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist.
Donderwinkel PF; Schoot DC; Pache TD; de Jong FH; Hop WC; Fauser BC
Hum Reprod; 1993 Dec; 8(12):2027-32. PubMed ID: 8150898
[TBL] [Abstract][Full Text] [Related]
4. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
Fauser BC; Donderwinkel P; Schoot DC
Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
[TBL] [Abstract][Full Text] [Related]
5. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
[TBL] [Abstract][Full Text] [Related]
6. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
Gersak K; Meden-Vrtovec H; Tomazevic T
Hum Reprod; 1994 Sep; 9(9):1596-9. PubMed ID: 7836506
[TBL] [Abstract][Full Text] [Related]
7. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
8. The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study.
van der Meer M; Hompes PG; Scheele F; Schoute E; Popp-Snijders C; Schoemaker J
Fertil Steril; 1996 Oct; 66(4):571-6. PubMed ID: 8816618
[TBL] [Abstract][Full Text] [Related]
9. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
van der Meer M; Hompes PG; Scheele F; Schoute E; Veersema S; Schoemaker J
Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
[TBL] [Abstract][Full Text] [Related]
10. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
Teissier MP; Chable H; Paulhac S; Aubard Y
Hum Reprod; 1999 Sep; 14(9):2236-41. PubMed ID: 10469686
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
13. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries.
Elting MW; Kwee J; Schats R; Rekers-Mombarg LT; Schoemaker J
J Clin Endocrinol Metab; 2001 Apr; 86(4):1589-95. PubMed ID: 11297588
[TBL] [Abstract][Full Text] [Related]
14. Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome.
Van Der Meer M; Hompes PG; De Boer JA; Schats R; Schoemaker J
J Clin Endocrinol Metab; 1998 Feb; 83(2):423-6. PubMed ID: 9467551
[TBL] [Abstract][Full Text] [Related]
15. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
16. Ovarian sensitivity to follicle-stimulating hormone during the follicular phase of the human menstrual cycle and in patients with polycystic ovarian syndrome.
Caruso A; Fortini A; Fulghesu AM; Pistilli E; Cucinelli F; Lanzone A; Mancuso S
Fertil Steril; 1993 Jan; 59(1):115-20. PubMed ID: 8419197
[TBL] [Abstract][Full Text] [Related]
17. Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome.
van der Meer M; de Boer JA; Hompes PG; Schoemaker J
Hum Reprod; 1998 Jun; 13(6):1465-9. PubMed ID: 9688372
[TBL] [Abstract][Full Text] [Related]
18. The role of endogenous gonadotropin release in the etiology of ovarian enlargement during purified urinary follicle-stimulating hormone therapy.
Mizunuma H; Takagi T; Yamada K; Andoh K; Ibuki Y; Igarashi M
Fertil Steril; 1991 Jan; 55(1):66-72. PubMed ID: 1898893
[TBL] [Abstract][Full Text] [Related]
19. Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome.
Farhi J; Jacobs HS
Fertil Steril; 1997 Mar; 67(3):459-62. PubMed ID: 9091330
[TBL] [Abstract][Full Text] [Related]
20. Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome.
Vrtacnik-Bokal E; Meden-Vrtovec H
Hum Reprod; 1998 Apr; 13(4):815-21. PubMed ID: 9619530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
